blood monitoring

Views & Analysis

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

News

A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.